Gut Microbiota-Medication Interaction in Rheumatic Diseases.

Area of Science:

• Microbiology
• Pharmacology
• Rheumatology

Background:

• The gut microbiota plays a role in rheumatic disease development.
• Intestinal microbes directly and indirectly influence anti-rheumatic drug metabolism.
• These interactions affect patient response and adverse drug effects.

Purpose of the Study:

• To review recent advances in understanding gut microbiota interactions with anti-rheumatic drugs.
• To provide perspectives on precision treatment and drug discovery for rheumatic diseases.

Main Methods:

• Literature review of current research on gut microbiota and anti-rheumatic drugs.
• Analysis of mechanisms of drug metabolism by intestinal microbiota.
• Exploration of host-microbiota interactions affecting drug response.

Main Results:

• Gut microbiota directly metabolize numerous anti-rheumatic drugs.
• Microbiota influence host metabolism, altering drug pharmacokinetics and pharmacodynamics.
• These interactions contribute to variability in therapeutic outcomes and toxicity.

Conclusions:

• Targeting gut microbiota interactions offers potential for precision medicine in rheumatology.
• Further research can guide novel drug discovery and improve anti-rheumatic therapies.
• Understanding the gut microbiome is crucial for optimizing treatment of rheumatic diseases.